| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica.
|
PLoS Pathog
|
2005
|
2.71
|
|
2
|
Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s.
|
J Bacteriol
|
2004
|
2.58
|
|
3
|
Multilocus sequence typing of Bordetella pertussis based on surface protein genes.
|
J Clin Microbiol
|
2002
|
2.02
|
|
4
|
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.
|
MBio
|
2014
|
1.76
|
|
5
|
Crucial role of antibodies to pertactin in Bordetella pertussis immunity.
|
J Infect Dis
|
2003
|
1.73
|
|
6
|
Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
|
Pediatr Infect Dis J
|
2008
|
1.69
|
|
7
|
Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.
|
PLoS One
|
2010
|
1.61
|
|
8
|
Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines.
|
Microbiology
|
2002
|
1.46
|
|
9
|
Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies.
|
Microbes Infect
|
2005
|
1.36
|
|
10
|
Small mutations in Bordetella pertussis are associated with selective sweeps.
|
PLoS One
|
2012
|
1.35
|
|
11
|
Comparative genomics of prevaccination and modern Bordetella pertussis strains.
|
BMC Genomics
|
2010
|
1.33
|
|
12
|
Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants?
|
J Infect Dis
|
2003
|
1.29
|
|
13
|
Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains.
|
BMC Genomics
|
2008
|
1.26
|
|
14
|
Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains.
|
PLoS One
|
2007
|
1.26
|
|
15
|
Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
|
Vaccine
|
2013
|
1.24
|
|
16
|
Pathogen adaptation under imperfect vaccination: implications for pertussis.
|
Proc Biol Sci
|
2005
|
1.24
|
|
17
|
Improving pertussis vaccination.
|
Hum Vaccin
|
2009
|
1.12
|
|
18
|
Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.
|
Infect Immun
|
2008
|
1.09
|
|
19
|
Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains.
|
Clin Vaccine Immunol
|
2007
|
1.05
|
|
20
|
Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis.
|
J Clin Microbiol
|
2007
|
1.04
|
|
21
|
Preclinical and clinical safety studies on DNA vaccines.
|
Hum Vaccin
|
2006
|
1.03
|
|
22
|
Bordetella pertussis clones identified by multilocus variable-number tandem-repeat analysis.
|
Emerg Infect Dis
|
2010
|
1.03
|
|
23
|
Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs.
|
Vaccine
|
2011
|
1.03
|
|
24
|
Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
|
Vaccine
|
2004
|
1.02
|
|
25
|
The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.
|
BMC Immunol
|
2008
|
0.99
|
|
26
|
Pertussis: a matter of immune modulation.
|
FEMS Microbiol Rev
|
2011
|
0.99
|
|
27
|
An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands.
|
Vaccine
|
2009
|
0.96
|
|
28
|
SNP-based typing: a useful tool to study Bordetella pertussis populations.
|
PLoS One
|
2011
|
0.93
|
|
29
|
Two-component cluster analysis of a large serodiagnostic database for specificity of increases of IgG antibodies against pertussis toxin in paired serum samples and of absolute values in single serum samples.
|
Clin Vaccine Immunol
|
2012
|
0.92
|
|
30
|
Studies on Prn variation in the mouse model and comparison with epidemiological data.
|
PLoS One
|
2011
|
0.91
|
|
31
|
The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coli.
|
Protein Expr Purif
|
2005
|
0.91
|
|
32
|
Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis.
|
Epidemiology
|
2012
|
0.90
|
|
33
|
Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen.
|
Infect Immun
|
2004
|
0.90
|
|
34
|
Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin.
|
Infect Immun
|
2008
|
0.89
|
|
35
|
Association of Bordetella pertussis with host immune cells in the mouse lung.
|
Microb Pathog
|
2003
|
0.88
|
|
36
|
Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies.
|
Vaccine
|
2009
|
0.88
|
|
37
|
Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.
|
J Clin Microbiol
|
2012
|
0.86
|
|
38
|
Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
|
Vaccine
|
2006
|
0.86
|
|
39
|
Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactin.
|
Scand J Infect Dis
|
2008
|
0.85
|
|
40
|
Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.
|
Clin Vaccine Immunol
|
2007
|
0.83
|
|
41
|
Bordetella pertussis isolates, Finland.
|
Emerg Infect Dis
|
2005
|
0.81
|
|
42
|
Whooping cough in Pakistan: Bordetella pertussis vs Bordetella parapertussis in 2005-2009.
|
Scand J Infect Dis
|
2011
|
0.81
|
|
43
|
Comparative gene expression profiling in two congenic mouse strains following Bordetella pertussis infection.
|
BMC Microbiol
|
2007
|
0.81
|
|
44
|
The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition.
|
Vaccine
|
2007
|
0.80
|
|
45
|
Complement evasion by Bordetella pertussis: implications for improving current vaccines.
|
J Mol Med (Berl)
|
2015
|
0.80
|
|
46
|
Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies.
|
Vaccine
|
2013
|
0.80
|
|
47
|
Molecular typing of Bordetella parapertussis isolates circulating in Pakistan.
|
FEMS Immunol Med Microbiol
|
2011
|
0.78
|
|
48
|
Characterization of Bordetella pertussis clinical isolates that do not express the tracheal colonization factor.
|
FEMS Immunol Med Microbiol
|
2007
|
0.77
|
|
49
|
A novel strategy to mimic discontinuous protective epitopes using a synthetic scaffold.
|
Vaccine
|
2007
|
0.76
|
|
50
|
Effects of a diphtheria-tetanus-acellular pertussis vaccine on immune responses in murine local lymph node and lung allergy models.
|
Clin Vaccine Immunol
|
2007
|
0.75
|
|
51
|
[Pertussis in the Netherlands].
|
Ned Tijdschr Geneeskd
|
2010
|
0.75
|
|
52
|
Pertussis in infancy and the association with respiratory and cognitive disorders at toddler age.
|
Vaccine
|
2011
|
0.75
|